Alert

Follow us

And stay informed in real time of the latest News!

Results for AML

Video

Related topics

ASH
ASH_hematology
mitochondria on the move bmscs fuel aml energy via bloodjournal leusm
Mitochondria on the move: BMSCs fuel #AML energy via @BloodJournal #leusm
Novartis
Novartis
Logo
novartis receives positive chmp opinion for tx of aml amp 3 types of advanced systemic mastocytosis in the eu
#Novartis receives positive #CHMP opinion for Tx of #AML & 3 types of advanced systemic #mastocytosis in the EU
ASH
ASH_hematology
venetoclax gets breakthrough therapy designation for aml via ashclinicalnews leusm
Venetoclax gets breakthrough-therapy designation for #AML via @ASHClinicalNews #leusm
Novartis
Novartis
Logo
novartis receives ema approval for treatment of aml amp 3 subtypes of systemic mastocytosis
#Novartis receives #EMA approval for treatment of #AML & 3 subtypes of systemic #mastocytosis
Novartis
Novartis
Logo
novartis receives fda approval for a new targeted therapy in aml amp three types of advanced systemic mastocyt
#Novartis receives #FDA approval for a new targeted therapy in #AML & three types of advanced systemic #mastocytosis
ASH
ASH_hematology
a scale of bad co mutations in npm1 driven aml via bloodjournal leusm
A scale of “bad” co-mutations in NPM1-driven #AML via @BloodJournal #leusm
European Commission
EU_Commission
press remarks by vdombrovskis after the ecofin council spain portugal aml euref
Press remarks by @VDombrovskis after the #ECOFIN council: #Spain #Portugal #AML #EUref
Novartis
Novartis
GIF
understanding genetic drivers of aml helps researchers target new treatments
Understanding genetic drivers of #AML helps researchers target new treatments.
Nature Medicine
NatureMedicine
a calcium amp calpain dependent pathway determines response to lenalidomide in aml and mds
A calcium-& calpain-dependent pathway determines response to lenalidomide in #AML and #MDS:
ASH
ASH_hematology
Logo
mutational analysis of disease relapse in patients allografted for acute myeloid leukemia via bloodadvances am
Mutational analysis of disease relapse in patients allografted for acute myeloid #leukemia via @BloodAdvances #AML
Total(1) => 0.31518292427063 f_f_QM(2) => 0.13808584213257 indS(2) => 0.015743970870972 indM(2) => 0.12223601341248 indM_1(2) => 0.019587755203247 indM_2(2) => 0.0015780925750732 indM_4(2) => 0.015984058380127 indM_5(2) => 0.030049085617065 indM_6(2) => 0.0020160675048828 indM_7(2) => 0.016966104507446 indM_8(2) => 0.0039741992950439 indM_9(2) => 0.0093009471893311 indM_10(2) => 0.0082671642303467 f_f_dT(61) => 0.11565446853638 f_f_pTL(2) => 0.10324311256409